<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04144959</url>
  </required_header>
  <id_info>
    <org_study_id>CLP 15549</org_study_id>
    <nct_id>NCT04144959</nct_id>
  </id_info>
  <brief_title>A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo Aspiration System</brief_title>
  <acronym>STRIDE</acronym>
  <official_title>STRIDE: A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo Aspiration System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Penumbra Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Penumbra Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to collect safety and performance data on the Indigo
      Aspiration System in a patient population with lower extremity acute limb ischemia (LE ALI).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 17, 2019</start_date>
  <completion_date type="Anticipated">December 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Target limb salvage rate</measure>
    <time_frame>1-Month Post Procedure</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Technical Success</measure>
    <time_frame>Immediate Post Procedure</time_frame>
    <description>Defined as TIMI 2/3 flow rate
TIMI flow grading range 1-3, with higher grading representing better outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Modified SVS runoff score</measure>
    <time_frame>Immediate Post Procedure</time_frame>
    <description>Immediate Post Procedure as compared to Baseline
Modified SVS runoff score ranges from 0-19, with a higher score indicating more severe disease</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement of Rutherford classification</measure>
    <time_frame>Up until study completion, at approximately 12-Months</time_frame>
    <description>Improvement of one or more as compared to pre-procedure
Rutherford classification ranges from I-III, with a higher score representing worse outcomes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vessel Patency</measure>
    <time_frame>1-Month Post-Procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target limb salvage rate</measure>
    <time_frame>12-Months Post Procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rates of device related serious adverse events (SAEs)</measure>
    <time_frame>Up until study completion, at approximately 12-Months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major bleeding peri-procedure</measure>
    <time_frame>During procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>12-Months</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">130</enrollment>
  <condition>Lower Extremity Acute Limb Ischemia</condition>
  <condition>LE ALI</condition>
  <arm_group>
    <arm_group_label>Patients with lower extremity acute limb ischemia</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Indigo Aspiration System</intervention_name>
    <description>Indigo Aspiration System</description>
    <arm_group_label>Patients with lower extremity acute limb ischemia</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients that present with LE ALI who are eligible for mechanical thrombectomy using the
        Indigao Aspiration System
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient age ≥ 18

          -  Patient presents with acute (≤14 days) occlusion of lower limb artery(ies) (below
             inguinal ligament)

          -  Patient with a Rutherford Category IIa or IIb score

          -  Frontline treatment with Indigo Aspiration System

          -  Informed consent is obtained from either patient or legally authorized representative
             (LAR)

        Exclusion Criteria:

          -  Life expectancy &lt;1 year

          -  Vessel size &lt;2 mm

          -  LE ALI secondary to dissections, vasculitis, and/or target vessel trauma

          -  Amputation in the ipsilateral limb

          -  Pregnancy or positive pregnancy test according to site specific standards of care
             (only required for women of child bearing potential, serum or urine acceptable)

          -  Absolute contraindication to contrast administration

          -  Patient is unwilling or unable to comply with protocol follow up schedule and/or based
             on the Investigator's judgment the patient is not a good study candidate

          -  Currently participating in an investigational drug or device clinical trial that may
             confound the study endpoints. Patients in observational, natural history, and/or
             epidemiological studies not involving intervention are eligible.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ella Reyes</last_name>
    <phone>+1 510 995 2343</phone>
    <email>ereyes@penumbrainc.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Michaella Corso</last_name>
    <phone>+1 510 995 2079</phone>
    <email>mcorso@penumbrainc.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Danbury Hospital</name>
      <address>
        <city>Danbury</city>
        <state>Connecticut</state>
        <zip>06810</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alan Dietzek, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Maryland</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>20742</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Khanjan Nagarsheth, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Albany Medical Center</name>
      <address>
        <city>Albany</city>
        <state>New York</state>
        <zip>12208</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul Kreienberg, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tisch Hospital NYU Langone Health</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Maldonado, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>NC Heart and Vascular Research</name>
      <address>
        <city>Cary</city>
        <state>North Carolina</state>
        <zip>27607</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Mendes, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Hardy, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sentara Vascular Specialists</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23507</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Dexter, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>October 14, 2019</study_first_submitted>
  <study_first_submitted_qc>October 28, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 30, 2019</study_first_posted>
  <last_update_submitted>July 16, 2020</last_update_submitted>
  <last_update_submitted_qc>July 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

